{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T17:57:20Z","timestamp":1762711040608,"version":"3.37.3"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["CS-2013-13-029"],"award-info":[{"award-number":["CS-2013-13-029"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obstructive sleep apnoea (OSA) is very common in patients with type 2 diabetes (T2D). We and others have shown that OSA was associated with diabetes-related microvascular complications in patients with T2D in cross-sectional and longitudinal studies and that compliance with continuous positive airway pressure (CPAP) reduced the progression of microvascular complications. Hence, we hypothesised that adequate CPAP reduces the development of microvascular complication in patients with T2D.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>SLEEP T2D is a cohort study with embedded feasibility, open-label, parallel-arm, randomised control trial (RCT) over 2\u2009years. The primary aim is the feasibility of conducting a definitive RCT assessing the impact of CPAP on chronic kidney disease and other microvascular complications in patients with T2D. The main parameters are to assess willingness of participants to be randomised, follow-up rates, CPAP adherence\/compliance, to optimise the choice of outcome measures for a substantive trial, and to identify the parameters for sample size calculations. The secondary aims of the study are related to the impact of CPAP, sleep-related disorders, and sleep chronotype on a variety of diabetes-related end points. The study participants were recruited from the T2D services in multiple NHS trusts across England. The main exclusion criteria for the cohort study are as follows: T1D, eGFR &lt;\u200915\u2009mL\/min\/1.73\u2009m<jats:sup>2<\/jats:sup>, known OSA, active malignancy or chronic kidney disease from reasons other than diabetes, pregnancy, professional drivers, and a history of falling asleep whilst driving within last 2 years. The main exclusion criteria from the RCT were as follows: Apnoea-Hypopnoea Index &lt;\u200910 and Epworth Sleepiness Score \u2265 11. Study participants were extensively phenotyped clinically and biochemically. The OSA diagnosis was based on multichannel portable device (ApneaLink Air<jats:sup>TM<\/jats:sup>, Resmed).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The feasibility RCT will help us design the future RCT to assess the impact of CPAP on diabetes-related microvascular complications. The cohort study will generate preliminary data regarding the impact of sleep quality, duration, and chronotype on diabetes-related outcomes which could lead to further mechanistic and interventional studies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ISRCTN, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN12361838\">ISRCTN12361838<\/jats:ext-link>. Registered 04 April 2018, Protocol version: v5.0 02.12.19.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40814-021-00817-z","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T08:03:29Z","timestamp":1616400209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial"],"prefix":"10.1186","volume":"7","author":[{"given":"Christina","family":"Antza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Ottridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smitaa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Slinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tearne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9037-1937","authenticated-orcid":false,"given":"Abd A.","family":"Tahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"5","key":"817_CR1","first-page":"355","volume":"94","author":"M Semelka","year":"2016","unstructured":"Semelka M, Wilson J, Floyd R. Diagnosis and treatment of obstructive sleep apnea in adults. Am Fam Physician. 2016;94(5):355\u201360.","journal-title":"Am Fam Physician."},{"issue":"7","key":"817_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/thx.50.7.797","volume":"50","author":"DP White","year":"1995","unstructured":"White DP. Sleep-related breathing disorder.2. Pathophysiology of obstructive sleep apnoea. Thorax. 1995;50(7):797\u2013804. https:\/\/doi.org\/10.1136\/thx.50.7.797.","journal-title":"Thorax."},{"issue":"3","key":"817_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5664\/jcsm.6506","volume":"13","author":"VK Kapur","year":"2017","unstructured":"Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical practice guideline. J Clin Sleep Med. 2017;13(3):479\u2013504. https:\/\/doi.org\/10.5664\/jcsm.6506.","journal-title":"J Clin Sleep Med"},{"key":"817_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.smrv.2016.07.002","volume":"34","author":"CV Senaratna","year":"2017","unstructured":"Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, Hamilton GS, Dharmage SC. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Reviews. 2017;34:70\u201381. https:\/\/doi.org\/10.1016\/j.smrv.2016.07.002.","journal-title":"Sleep Med Reviews."},{"issue":"12","key":"817_CR5","first-page":"1077","volume":"20","author":"SF Quan","year":"1997","unstructured":"Quan SF, Howard BV, Iber C, Kiley JP, Nieto FJ, O\u2019Connor GT, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep. 1997;20(12):1077\u201385.","journal-title":"Sleep."},{"issue":"17","key":"817_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJM199304293281704","volume":"328","author":"T Young","year":"1993","unstructured":"Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. New England J Med. 1993;328(17):1230\u20135. https:\/\/doi.org\/10.1056\/NEJM199304293281704.","journal-title":"New England J Med"},{"issue":"9","key":"817_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314. https:\/\/doi.org\/10.1093\/aje\/kws342.","journal-title":"Am J Epidemiol."},{"issue":"2","key":"817_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.201312-2209OC","volume":"190","author":"T Kendzerska","year":"2014","unstructured":"Kendzerska T, Gershon AS, Hawker G, Tomlinson G, Leung RS. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respiratory Critical Care Med. 2014;190(2):218\u201325. https:\/\/doi.org\/10.1164\/rccm.201312-2209OC.","journal-title":"Am J Respiratory Critical Care Med"},{"issue":"1","key":"817_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5664\/jcsm.27387","volume":"5","author":"NS Marshall","year":"2009","unstructured":"Marshall NS, Wong KK, Phillips CL, Liu PY, Knuiman MW, Grunstein RR. Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study? J Clin Sleep Med. 2009;5(1):15\u201320.","journal-title":"J Clin Sleep Med"},{"key":"817_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.sleep.2016.05.009","volume":"25","author":"M Nagayoshi","year":"2016","unstructured":"Nagayoshi M, Punjabi NM, Selvin E, Pankow JS, Shahar E, Iso H, Folsom AR, Lutsey PL. Obstructive sleep apnea and incident type 2 diabetes. Sleep Med. 2016;25:156\u201361. https:\/\/doi.org\/10.1016\/j.sleep.2016.05.009.","journal-title":"Sleep Med"},{"key":"817_CR11","doi-asserted-by":"crossref","unstructured":"Subramanian A, Adderley NJ. Risk of incident obstructive sleep apnea among patients with type 2 diabetes. Diab Care. 2019;42(5):954-63.","DOI":"10.2337\/dc18-2004"},{"issue":"4","key":"817_CR12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4158\/EP.13.4.355","volume":"13","author":"D Einhorn","year":"2007","unstructured":"Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocrine Practice. 2007;13(4):355\u201362. https:\/\/doi.org\/10.4158\/EP.13.4.355.","journal-title":"Endocrine Practice"},{"issue":"6","key":"817_CR13","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2337\/dc08-1776","volume":"32","author":"GD Foster","year":"2009","unstructured":"Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Pi Sunyer FX, Darcey V, Kuna ST, for the Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32(6):1017\u20139. https:\/\/doi.org\/10.2337\/dc08-1776.","journal-title":"Diabetes Care."},{"issue":"3","key":"817_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1752-699X.2010.00216.x","volume":"5","author":"AK Schober","year":"2011","unstructured":"Schober AK, Neurath MF, Harsch IA. Prevalence of sleep apnoea in diabetic patients. Clin Respiratory J. 2011;5(3):165\u201372. https:\/\/doi.org\/10.1111\/j.1752-699X.2010.00216.x.","journal-title":"Clin Respiratory J"},{"issue":"9","key":"817_CR15","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2337\/dc11-2076","volume":"35","author":"AA Tahrani","year":"2012","unstructured":"Tahrani AA, Zeng W, Shakher J, Piya MK, Hughes S, Dubb K, Stevens MJ. Cutaneous structural and biochemical correlates of foot complications in high-risk diabetes. Diabetes Care. 2012;35(9):1913\u20138. https:\/\/doi.org\/10.2337\/dc11-2076.","journal-title":"Diabetes Care."},{"issue":"11","key":"817_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1136\/thx.2005.057745","volume":"61","author":"SD West","year":"2006","unstructured":"West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006;61(11):945\u201350. https:\/\/doi.org\/10.1136\/thx.2005.057745.","journal-title":"Thorax."},{"issue":"5","key":"817_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.diabet.2009.03.007","volume":"35","author":"JP Laaban","year":"2009","unstructured":"Laaban JP, Daenen S, Leger D, Pascal S, Bayon V, Slama G, et al. Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes Metab. 2009;35(5):372\u20137. https:\/\/doi.org\/10.1016\/j.diabet.2009.03.007.","journal-title":"Diabetes Metab"},{"issue":"4","key":"817_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.5664\/jcsm.6548","volume":"13","author":"A Amin","year":"2017","unstructured":"Amin A, Ali A, Altaf QA, Piya MK, Barnett AH, Raymond NT, Tahrani AA. Prevalence and associations of obstructive sleep apnea in South Asians and White Europeans with type 2 diabetes: a cross-sectional study. J Clin Sleep Med. 2017;13(4):583\u20139. https:\/\/doi.org\/10.5664\/jcsm.6548.","journal-title":"J Clin Sleep Med"},{"issue":"9","key":"817_CR19","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1089\/dia.2011.0005","volume":"13","author":"A Pillai","year":"2011","unstructured":"Pillai A, Warren G, Gunathilake W, Idris I. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther. 2011;13(9):945\u20139. https:\/\/doi.org\/10.1089\/dia.2011.0005.","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"817_CR20","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","volume":"4","author":"JR Brownrigg","year":"2016","unstructured":"Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ, et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 2016;4(7):588\u201397. https:\/\/doi.org\/10.1016\/S2213-8587(16)30057-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"817_CR21","volume-title":"Diabetes: cases and costs predicted to rise","author":"NHS","year":"2012","unstructured":"NHS. Diabetes: cases and costs predicted to rise. 2012."},{"issue":"6865","key":"817_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813\u201320. https:\/\/doi.org\/10.1038\/414813a.","journal-title":"Nature."},{"issue":"6","key":"817_CR23","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615\u201325. https:\/\/doi.org\/10.2337\/diabetes.54.6.1615.","journal-title":"Diabetes."},{"issue":"4","key":"817_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1517\/14728214.2010.512610","volume":"15","author":"AA Tahrani","year":"2010","unstructured":"Tahrani AA, Askwith T, Stevens MJ. Emerging drugs for diabetic neuropathy. Expert Opin Emerg Drugs. 2010;15(4):661\u201383. https:\/\/doi.org\/10.1517\/14728214.2010.512610.","journal-title":"Expert Opin Emerg Drugs."},{"issue":"2","key":"817_CR25","doi-asserted-by":"publisher","first-page":"H920","DOI":"10.1152\/ajpheart.01264.2007","volume":"294","author":"KJ Allahdadi","year":"2008","unstructured":"Allahdadi KJ, Duling LC, Walker BR, Kanagy NL. Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: role of PKCdelta. Am J Physiol Heart Circ Physiol. 2008;294(2):H920\u20137. https:\/\/doi.org\/10.1152\/ajpheart.01264.2007.","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"4","key":"817_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/sleep\/32.4.447","volume":"32","author":"ES Arnardottir","year":"2009","unstructured":"Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009;32(4):447\u201370. https:\/\/doi.org\/10.1093\/sleep\/32.4.447.","journal-title":"Sleep."},{"issue":"5","key":"817_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pcad.2008.08.002","volume":"51","author":"A Atkeson","year":"2009","unstructured":"Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis. 2009;51(5):351\u201362. https:\/\/doi.org\/10.1016\/j.pcad.2008.08.002.","journal-title":"Prog Cardiovasc Dis."},{"issue":"4","key":"817_CR28","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1034\/j.1399-3003.2000.16d13.x","volume":"16","author":"A Barcelo","year":"2000","unstructured":"Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respiratory J. 2000;16(4):644\u20137. https:\/\/doi.org\/10.1034\/j.1399-3003.2000.16d13.x.","journal-title":"Eur Respiratory J"},{"issue":"4","key":"817_CR29","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1378\/chest.124.4.1386","volume":"124","author":"GE Carpagnano","year":"2003","unstructured":"Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003;124(4):1386\u201392. https:\/\/doi.org\/10.1378\/chest.124.4.1386.","journal-title":"Chest."},{"issue":"1","key":"817_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000109643","volume":"76","author":"M de la Pena","year":"2008","unstructured":"de la Pena M, Barcelo A, Barbe F, Pierola J, Pons J, Rimbau E, et al. Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration. 2008;76(1):28\u201332. https:\/\/doi.org\/10.1159\/000109643.","journal-title":"Respiration."},{"issue":"7","key":"817_CR31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1164\/ajrccm.165.7.2104126","volume":"165","author":"L Dyugovskaya","year":"2002","unstructured":"Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respiratory Critical Care Med. 2002;165(7):934\u20139. https:\/\/doi.org\/10.1164\/ajrccm.165.7.2104126.","journal-title":"Am J Respiratory Critical Care Med"},{"issue":"8","key":"817_CR32","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/CIRCULATIONAHA.109.900357","volume":"121","author":"S Jelic","year":"2010","unstructured":"Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, le Jemtel TH. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121(8):1014\u201321. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.900357.","journal-title":"Circulation."},{"issue":"4","key":"817_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pcad.2008.08.003","volume":"51","author":"L Lavie","year":"2009","unstructured":"Lavie L. Oxidative stress--a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 2009;51(4):303\u201312. https:\/\/doi.org\/10.1016\/j.pcad.2008.08.003.","journal-title":"Prog Cardiovasc Dis."},{"issue":"1","key":"817_CR34","first-page":"123","volume":"27","author":"L Lavie","year":"2004","unstructured":"Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004;27(1):123\u20138.","journal-title":"Sleep."},{"issue":"2","key":"817_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1183\/09031936.06.00084905","volume":"28","author":"K Minoguchi","year":"2006","unstructured":"Minoguchi K, Yokoe T, Tanaka A, Ohta S, Hirano T, Yoshino G, et al. Association between lipid peroxidation and inflammation in obstructive sleep apnoea. Eur Respiratory J. 2006;28(2):378\u201385. https:\/\/doi.org\/10.1183\/09031936.06.00084905.","journal-title":"Eur Respiratory J"},{"issue":"1","key":"817_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000095675","volume":"74","author":"N Peled","year":"2007","unstructured":"Peled N, Shitrit D, Bendayan D, Peled E, Kramer MR. Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration. 2007;74(1):50\u20135. https:\/\/doi.org\/10.1159\/000095675.","journal-title":"Respiration."},{"issue":"3","key":"817_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/sleep\/18.3.188","volume":"18","author":"C Rangemark","year":"1995","unstructured":"Rangemark C, Hedner JA, Carlson JT, Gleerup G, Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep. 1995;18(3):188\u201394. https:\/\/doi.org\/10.1093\/sleep\/18.3.188.","journal-title":"Sleep."},{"issue":"5","key":"817_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1515\/CCLM.1999.083","volume":"37","author":"S Saarelainen","year":"1999","unstructured":"Saarelainen S, Lehtimaki T, Jaak-kola O, Poussa T, Nikkila M, Solakivi T, et al. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med. 1999;37(5):517\u201320.","journal-title":"Clin Chem Lab Med."},{"issue":"1","key":"817_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1164\/ajrccm.165.1.2101062","volume":"165","author":"R Schulz","year":"2002","unstructured":"Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respiratory Critical Care Med. 2002;165(1):67\u201370. https:\/\/doi.org\/10.1164\/ajrccm.165.1.2101062.","journal-title":"Am J Respiratory Critical Care Med"},{"issue":"2 Pt 1","key":"817_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1164\/ajrccm.162.2.9908091","volume":"162","author":"R Schulz","year":"2000","unstructured":"Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respiratory Critical Care Med. 2000;162(2 Pt 1):566\u201370. https:\/\/doi.org\/10.1164\/ajrccm.162.2.9908091.","journal-title":"Am J Respiratory Critical Care Med"},{"issue":"3","key":"817_CR41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/sleep\/29.3.329","volume":"29","author":"KC Tan","year":"2006","unstructured":"Tan KC, Chow WS, Lam JC, Lam B, Bucala R, Betteridge J, et al. Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea. Sleep. 2006;29(3):329\u201333. https:\/\/doi.org\/10.1093\/sleep\/29.3.329.","journal-title":"Sleep."},{"issue":"2","key":"817_CR42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1513\/pats.200708-139MG","volume":"5","author":"E Tasali","year":"2008","unstructured":"Tasali E, Ip MS. Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc. 2008;5(2):207\u201317. https:\/\/doi.org\/10.1513\/pats.200708-139MG.","journal-title":"Proc Am Thorac Soc."},{"issue":"12","key":"817_CR43","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.rmed.2004.04.009","volume":"98","author":"A Valipour","year":"2004","unstructured":"Valipour A, Litschauer B, Mittermayer F, Rauscher H, Burghuber OC, Wolzt M. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med. 2004;98(12):1180\u20136. https:\/\/doi.org\/10.1016\/j.rmed.2004.04.009.","journal-title":"Respir Med."},{"issue":"2","key":"817_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuroscience.2004.03.055","volume":"126","author":"W Xu","year":"2004","unstructured":"Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, Luo C, Kheirandish L, Gozal D, Liu R. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126(2):313\u201323. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.03.055.","journal-title":"Neuroscience."},{"issue":"5","key":"817_CR45","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1378\/chest.127.5.1674","volume":"127","author":"M Yamauchi","year":"2005","unstructured":"Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H. Oxidative stress in obstructive sleep apnea. Chest. 2005;127(5):1674\u20139. https:\/\/doi.org\/10.1378\/chest.127.5.1674.","journal-title":"Chest."},{"issue":"11","key":"817_CR46","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.2337\/dc13-0450","volume":"36","author":"AA Tahrani","year":"2013","unstructured":"Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Altaf QA, Piya MK, Barnett AH, Stevens MJ. Obstructive sleep apnea and diabetic nephropathy: a cohort study. Diabetes Care. 2013;36(11):3718\u201325. https:\/\/doi.org\/10.2337\/dc13-0450.","journal-title":"Diabetes Care."},{"issue":"3","key":"817_CR47","first-page":"449","volume":"23","author":"A Tahrani","year":"2013","unstructured":"Tahrani A, Dodson P, Ali A, Altaf Q, Wharton H, Raymond NT, et al. Obstructive sleep apnoea is associated with sight threatening retinopathy and predicts the development of preproliferative and proliferative retinopathy in patients with type 2 diabetes: a longitudinal analysis. Eur J Ophthalmol. 2013;23(3):449.","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"817_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2169\/internalmedicine.52.8468","volume":"52","author":"S Koga","year":"2013","unstructured":"Koga S, Ikeda S, Yasunaga T, Nakata T, Maemura K. Effects of nasal continuous positive airway pressure on the glomerular filtration rate in patients with obstructive sleep apnea syndrome. Internal Med. 2013;52(3):345\u20139.","journal-title":"Internal Med"},{"key":"817_CR49","unstructured":"Pinto VL SS. Continuous positive airway pressure (CPAP) [Updated 2019 May 11]. StatPearls [Internet]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482178\/."},{"key":"817_CR50","unstructured":"Excellence NIfHaC. Continuous positive airway pressure for the treatment of obstructive sleep apnoea\/hypopnoea syndrome. NICE technology appraisal guidance 139. 2008."},{"issue":"10","key":"817_CR51","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. New England J Med. 2016;375(10):919\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1606599.","journal-title":"New England J Med"},{"issue":"10","key":"817_CR52","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-2600(14)70172-9","volume":"2","author":"A McMillan","year":"2014","unstructured":"McMillan A, Bratton DJ, Faria R, Laskawiec-Szkonter M, Griffin S, Davies RJ, Nunn AJ, Stradling JR, Riha RL, Morrell MJ, PREDICT Investigators. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. Lancet Respiratory Med. 2014;2(10):804\u201312. https:\/\/doi.org\/10.1016\/S2213-2600(14)70172-9.","journal-title":"Lancet Respiratory Med"},{"key":"817_CR53","doi-asserted-by":"publisher","unstructured":"West SD, Prudon B, Hughes J, Gupta R, Mohammed SB, Gerry S, et al. Continuous positive airway pressure effect on visual acuity in patients with type 2 diabetes and obstructive sleep apnoea: a multicentre randomised controlled trial. Eur Respir J. 2018;52(4):1801177. https:\/\/doi.org\/10.1183\/13993003.01177-2018. Print 2018 Oct.","DOI":"10.1183\/13993003.01177-2018"},{"issue":"12","key":"817_CR54","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.5664\/jcsm.4272","volume":"10","author":"RB Berry","year":"2014","unstructured":"Berry RB, Sriram P. Auto-adjusting positive airway pressure treatment for sleep apnea diagnosed by home sleep testing. J Clin sleep Med. 2014;10(12):1269\u201375.","journal-title":"J Clin sleep Med"},{"issue":"5","key":"817_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.5664\/jcsm.3686","volume":"10","author":"S Batool-Anwar","year":"2014","unstructured":"Batool-Anwar S, Goodwin JL, Drescher AA, Baldwin CM, Simon RD, Smith TW, Quan SF. Impact of CPAP on activity patterns and diet in patients with obstructive sleep apnea (OSA). J Clin Sleep Med. 2014;10(5):465\u201372. https:\/\/doi.org\/10.5664\/jcsm.3686.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"817_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.sleep.2011.09.005","volume":"13","author":"IS Lee","year":"2012","unstructured":"Lee IS, Bardwell W, Ancoli-Israel S, Loredo JS, Dimsdale JE. Effect of three weeks of continuous positive airway pressure treatment on mood in patients with obstructive sleep apnoea: a randomized placebo-controlled study. Sleep medicine. 2012;13(2):161\u20136. https:\/\/doi.org\/10.1016\/j.sleep.2011.09.005.","journal-title":"Sleep medicine."},{"issue":"20","key":"817_CR57","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/jama.2012.4366","volume":"307","author":"F Barbe","year":"2012","unstructured":"Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, Martinez-Alonso M, Carmona C, Barcelo A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307(20):2161\u20138. https:\/\/doi.org\/10.1001\/jama.2012.4366.","journal-title":"JAMA."},{"issue":"12","key":"817_CR58","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/thoraxjnl-2012-202178","volume":"67","author":"SE Craig","year":"2012","unstructured":"Craig SE, Kohler M, Nicoll D, Bratton DJ, Nunn A, Davies R, Stradling J. Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax. 2012;67(12):1090\u20136. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202178.","journal-title":"Thorax."},{"issue":"11","key":"817_CR59","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1210\/jc.2012-2107","volume":"97","author":"PC Myhill","year":"2012","unstructured":"Myhill PC, Davis WA, Peters KE, Chubb SA, Hillman D, Davis TM. Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea. J Clin Endocrinol Metab. 2012;97(11):4212\u20138. https:\/\/doi.org\/10.1210\/jc.2012-2107.","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"817_CR60","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.sleep.2012.04.007","volume":"13","author":"A Tamura","year":"2012","unstructured":"Tamura A, Kawano Y, Watanabe T, Kadota J. Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med. 2012;13(8):1050\u20135. https:\/\/doi.org\/10.1016\/j.sleep.2012.04.007.","journal-title":"Sleep Med"},{"key":"817_CR61","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.smrv.2016.02.001","volume":"31","author":"SWH Lee","year":"2017","unstructured":"Lee SWH, Ng KY, Chin WK. The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Reviews. 2017;31:91\u2013101. https:\/\/doi.org\/10.1016\/j.smrv.2016.02.001.","journal-title":"Sleep Med Reviews."},{"key":"817_CR62","doi-asserted-by":"publisher","unstructured":"Chirwa S, Nwabuisi CR, Ladson GM, Korley L, Whitty JE, Atkinson R, et al. Poor sleep quality is associated with higher hemoglobin A1c in pregnant women: a pilot observational study. Int J Environ Res Public Health. 2018;15(10):2287. https:\/\/doi.org\/10.3390\/ijerph15102287.","DOI":"10.3390\/ijerph15102287"},{"key":"817_CR63","doi-asserted-by":"publisher","unstructured":"Whitaker KM, Lutsey PL, Ogilvie RP, Pankow JS, Bertoni A, Michos ED, et al. Associations between polysomnography and actigraphy-based sleep indices and glycemic control among those with and without type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis. Sleep. 2018;41(11):zsy172. https:\/\/doi.org\/10.1093\/sleep\/zsy172.","DOI":"10.1093\/sleep\/zsy172"},{"key":"817_CR64","doi-asserted-by":"publisher","unstructured":"Sakamoto R, Yamakawa T. Association of usual sleep quality and glycemic control in type 2 diabetes in Japanese: a cross sectional study. Sleep Food Registry Kanagawa (SOREKA). PLoS One. 2018;13(1):e0191771. https:\/\/doi.org\/10.1371\/journal.pone.0191771. eCollection 2018.","DOI":"10.1371\/journal.pone.0191771"},{"key":"817_CR65","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0125","volume-title":"Deterioration of sleep quality according to glycemic status","author":"MH Hur","year":"2020","unstructured":"Hur MH, Lee MK, Seong K, Hong JH. Deterioration of sleep quality according to glycemic status; 2020."},{"key":"817_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.sleep.2018.10.034","volume":"54","author":"FJ Franke","year":"2019","unstructured":"Franke FJ, Arzt M, Kroner T, Gorski M, Heid IM, B\u00f6ger CA, Jung B, Zeman F, Stadler S, DIACORE Study Group. Daytime napping and diabetes-associated kidney disease. Sleep Med. 2019;54:205\u201312. https:\/\/doi.org\/10.1016\/j.sleep.2018.10.034.","journal-title":"Sleep Med"},{"issue":"12","key":"817_CR67","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1464-5491.2003.01077.x","volume":"20","author":"S Harding","year":"2003","unstructured":"Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R, Kohner E, Scanlon P, Leese G, The Diabetic Retinopathy Grading and Disease Management Working Party. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med. 2003;20(12):965\u201371. https:\/\/doi.org\/10.1111\/j.1464-5491.2003.01077.x.","journal-title":"Diabet Med."},{"key":"817_CR68","unstructured":"National Institute of Health Research (NIHR). Guidance on applying for feasibility studies [updated 2019]. Available from: https:\/\/www.nihr.ac.uk\/documents\/nihr-research-for-patient-benefit-rfpb-programme-guidance-on-applying-for-feasibility-studies\/20474"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-021-00817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40814-021-00817-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-021-00817-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T08:05:13Z","timestamp":1616400313000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-021-00817-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["817"],"URL":"https:\/\/doi.org\/10.1186\/s40814-021-00817-z","relation":{},"ISSN":["2055-5784"],"issn-type":[{"type":"electronic","value":"2055-5784"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"1 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"National Research Ethics Committee West Midlands \u2013 The Black Country, reference 18\/WM\/0070.The conduct of the study will be in accordance with the principles of Good Clinical Practice. The participant\u2019s written informed consent to participate in the study will be obtained before any procedures relating to the study are undertaken and after a full explanation has been given of the study, the treatment options, and the manner of treatment allocation and randomisation. Two Participant Information Sheets (PIS) will be provided to facilitate this process, one for the study as a whole, and one for the RCT. They will also stress that participation is voluntary and that the participant is free to refuse to take part and may withdraw from the study at any time. The participant will be given sufficient time to read the PIS and to discuss their participation with others outside of the site research team. The participant will be given the opportunity to ask questions prior to signing and dating the latest version of the consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}